跳至主要内容
临床试验/NCT04402554
NCT04402554已完成不适用

Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 501 人开始时间: 2020年5月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
501
试验地点
1
主要终点
prevalence of cannabis use in patients with chronic inflammatory rheumatic conditions

研究概览

简要总结

Patients with inflammatory rheumatism very often have residual pain that is not easily relieved by conventional treatments. They can then use non-drug methods, such as physiotherapy, hypnosis or even cannabis.

The aim of this study is to assess the percentage of patients who use cannabis to better relieve their pain or anxiety in chronic inflammatory rheumatism.

详细描述

Thanks to a better understanding of the pathophysiological mechanisms of inflammatory rheumatism, rheumatology has known for several decades a growth in its therapeutic arsenal (csDMARDs, bDMARDs, tDMARDs). rheumatism control has thus been optimized.

however, patients very often keep pain, anxiety, residual fatigue, poorly controlled by our conventional therapies. patients then turn to non-drug therapies, among which the use of cannabis.

endocannabinoids have an analgesic and anti-inflammatory action recognized in pre-clinical trials. however, investigators currently lack the data to authorize its use in clinical rheumatology.

the aim of this study is to determine the prevalence of cannabis users in patients with rheumatoid arthritis, ankylosing spondyloarthritis or psoriatic arthritis in our unit. as a second intention, investigators will refine the consumption characteristics. Investigators will also look for possible risk factors for consumption (sensitivity to pain, catastrophism, standard of living, anxiety, depression, rheumatic activity and quality of life).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rheumatoid Arthritis (ACR 2010 Criteria)
  • Ankylosing Spondylitis (New york or ASAS criteria)
  • Psoriatic Arthritis (CASPAR criteria)

排除标准

  • Patient unable to complete questionnaires or unable to express informed consent
  • Guardianship, trusteeship, deprivation of liberties, safeguard of justice

结局指标

主要结局

prevalence of cannabis use in patients with chronic inflammatory rheumatic conditions

时间窗: Day 0

Patients will answer the following question: Are you currently using cannabis - Yes or No

次要结局

  • Assessing the association between cannabis use and disease activity of spondylitis ankylosing(Day 0)
  • Percentage of patients with problematic cannabis use(Day 0)
  • Assessing the association between cannabis use and functional disability(Day 0)
  • Assessing the association between cannabis use and Anxiety/Depression(Day 0)
  • Assessing the association between cannabis use and disease activity of rheumatoid arthritis / psoriatic arthritis(Day 0)
  • Assessing the association between cannabis use and social vulnerability(Day 0)
  • Assessing the association between cannabis use and pain catastrophism(Day 0)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验